Cargando…

Mifepristone Improves Octreotide Efficacy in Resistant Ectopic Cushing's Syndrome

A 30-year-old Caucasian man presented with severe Cushing's syndrome (CS) resulting from ectopic adrenocorticotropin syndrome (EAS) from a metastatic pancreatic neuroendocrine tumor. The patient remained hypercortisolemic despite treatment with steroidogenesis inhibitors, chemotherapy, and octr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moraitis, Andreas G., Auchus, Richard J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773543/ https://www.ncbi.nlm.nih.gov/pubmed/26989527 http://dx.doi.org/10.1155/2016/8453801

Ejemplares similares

ODP322 Impact of Mifepristone on Liver Function and Resolution of Liver Steatosis in Patients with Cushing Syndrome – A Case Study
por: East, Honey E, et al.
Publicado: (2022)

SUN-460 Anticipating Hypokalemia in Patients With ACTH-Dependent Cushing Syndrome Treated With Mifepristone: Utilization of Cortisol and ACTH Levels to Identify At-Risk Patients
por: Moraitis, Andreas, et al.
Publicado: (2019)

SUN-451 A Randomized-Withdrawal, Placebo-Controlled, Phase 3 Study to Assess the Efficacy and Safety of Selective Glucocorticoid Receptor Antagonist, Relacorilant, in Patients with Cushing Syndrome (GRACE Study)
por: Auchus, Richard, et al.
Publicado: (2019)

THU621 Mifepristone In Exogenous Cushing's Syndrome
por: Priyadarshan, Swetha, et al.
Publicado: (2023)

Mifepristone for Treatment of Metabolic Syndrome: Beyond Cushing’s Syndrome
por: Díaz-Castro, Francisco, et al.
Publicado: (2020)

Metastatic hepatic carcinoid associated with ectopic ACTH syndrome, resistant to octreotide and ketoconazole therapy
por: Khan, Mohammed Qassim, et al.
Publicado: (2004)

Biochemical and Radiological Changes in Liver Steatosis Following Mifepristone Treatment in Patients With Hypercortisolism
por: Parker, John C., et al.
Publicado: (2021)

Mifepristone as Bridge or Adjunct Therapy in the Management of Challenging Cushing Disease Cases
por: Chang, Alice Y, et al.
Publicado: (2021)

Hypokalemia associated with mifepristone use in the treatment of Cushing’s syndrome
por: Sai, Katta, et al.
Publicado: (2019)

Mifepristone induced liver injury in a patient with Cushing syndrome: a case report and review of the literature
por: Ault, Taylor A., et al.
Publicado: (2023)

A Challenging Case of an Ectopic Cushing Syndrome
por: Menezes Nunes, Joana, et al.
Publicado: (2014)

Ectopic Cushing's Syndrome Secondary to Metastatic Paraganglioma
por: Daya, R., et al.
Publicado: (2021)

Effects of Mifepristone on Nonalcoholic Fatty Liver Disease in a Patient with a Cortisol-Secreting Adrenal Adenoma
por: Ragucci, Enzo, et al.
Publicado: (2017)

Global clinical response in Cushing’s syndrome patients treated with mifepristone
por: Katznelson, Laurence, et al.
Publicado: (2014)

Adrenocorticotropic Hormone-Secreting Esthesioneuroblastoma with Ectopic Cushing's Syndrome
por: Chung, Young Soo, et al.
Publicado: (2020)

Clival Ectopic Pituitary Adenoma Causing Cushing Syndrome
por: Karthik, Subramaniam, et al.
Publicado: (2023)

Improvement in Insulin Sensitivity During Mifepristone Treatment of Cushing Syndrome:Early and Late Effects
por: Wallia, Amisha, et al.
Publicado: (2013)

Clinical management of patients with Cushing syndrome treated with mifepristone: consensus recommendations
por: Brown, David R., et al.
Publicado: (2020)

Ectopic Cushing’s syndrome secondary to olfactory neuroblastoma
por: Yu, Kenny, et al.
Publicado: (2018)

Successful Treatment with Selpercatinib for Ectopic Cushing’s Syndrome Due to Medullary Thyroid Cancer
por: Ragnarsson, Oskar, et al.
Publicado: (2022)

Ectopic Cushing' syndrome caused by a neuroendocrine carcinoma of the mesentery
por: Fasshauer, Mathias, et al.
Publicado: (2006)

Ectopic Cushing's Syndrome Unveiling a Metastatic Parotid Carcinoma
por: Castro Oliveira, Sofia, et al.
Publicado: (2019)

The Development of Hypogonadotropic Hypogonadism After Starting Low Dose Mifepristone for Cushing’s Syndrome
por: Rowell, Jennifer Voigt
Publicado: (2021)

Citalopram/octreotide: Carcinoid heart disease, unmasking of carcinoid syndrome and development of octreotide resistance: case report
Publicado: (2021)

Cushing’s syndrome due to ectopic adrenocorticotropin secretion by a parotid carcinoma
por: Antonacio, Fernanda F., et al.
Publicado: (2022)

Long-term Treatment With Metyrapone in a Man With Ectopic Cushing Syndrome
por: Wong, Tin Wai
Publicado: (2022)

Ectopic Cushing’s syndrome due to a mesenteric neuroendocrine tumour
por: Mashoori, N, et al.
Publicado: (2012)

Ectopic Cushing syndrome in Colombia
por: Lopez-Montoya, Vanessa, et al.
Publicado: (2020)

Evaluation of Evidence of Adrenal Insufficiency in Trials of Normocortisolemic Patients Treated With Mifepristone
por: Yuen, Kevin C. J., et al.
Publicado: (2017)

Utilization of bilateral percutaneous microwave ablation of the adrenal glands in ectopic Cushing's syndrome
por: Petty, Lloyd, et al.
Publicado: (2022)

Successful Management of Cushing Syndrome From Ectopic ACTH Secretion in an Adolescent With Osilodrostat
por: Blew, Kathryn, et al.
Publicado: (2023)

Case report: nocardia infection associated with ectopic cushings
por: Rizwan, Azra, et al.
Publicado: (2014)

The Elusive Neuroendocrine Tumor: Finding the Ectopic ACTH Source 16 Years After the Diagnosis of Cushing Syndrome
por: Smushkin, Galina, et al.
Publicado: (2023)

Interstitial Ectopic Pregnancy: The Role of Mifepristone in the Medical Treatment
por: Stabile, Guglielmo, et al.
Publicado: (2021)

Ectopic Cushing’s syndrome due to adrenocorticotropic hormone secreting atypical thymic carcinoid tumor
por: Duran, Cevdet, et al.
Publicado: (2018)

Ectopic Cushing’s syndrome associated with a pheochromocytoma in a dog: a case report
por: Lee, Sungin, et al.
Publicado: (2020)

Mifepristone-Induced Hypothyroidism
por: Kalara, Niketa, et al.
Publicado: (2023)

SUN-186 Case Report: Mifepristone Taper in an Individual with Equivocal Cushing’s Syndrome Screening Tests
por: Martin, Christopher, et al.
Publicado: (2020)

Glucocorticoid Withdrawal Syndrome following treatment of endogenous Cushing Syndrome
por: He, Xin, et al.
Publicado: (2022)

Endoscopic bilateral adrenalectomy in patients with ectopic Cushing’s syndrome
por: Alberda, Wijnand J., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_b5ou81cj4dh72atq5kqdc1p7sq